Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002100119-26-001087
Filing Date
2026-04-30
Accepted
2026-04-30 13:54:29
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5683
  Complete submission text file 0002100119-26-001087.txt   7386
Mailing Address 200 MINUTEMAN ROAD ANDOVER MA 01810
Business Address 200 MINUTEMAN ROAD ANDOVER MA 01810 9785520900
TransMedics Group, Inc. (Subject) CIK: 0001756262 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91061 | Film No.: 26922977
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 100 VANGUARD BLVD MALVERN PA 19355
Business Address 100 VANGUARD BLVD MALVERN PA 19355 610-669-6148
VANGUARD CAPITAL MANAGEMENT LLC (Filed by) CIK: 0002100119 (see all company filings)

EIN.: 392877419 | State of Incorp.: PA | Fiscal Year End: 1231
LEI: 529900ZEWTRLEJ6XE960
Type: SCHEDULE 13G